Mycenax Biotech Revenue

In the year 2024, Mycenax Biotech had annual revenue of 683.92M TWD with 4.80% growth. Mycenax Biotech had revenue of 193.99M in the quarter ending December 31, 2024, with 6.05% growth.

Revenue

683.92M

Revenue Growth

+4.80%

P/S Ratio

9.32

Revenue / Employee

1.77M

Employees

387

Market Cap

6.38B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	683.92M	31.30M	4.80%
Dec 31, 2023	652.62M	-79.66M	-10.88%
Dec 31, 2022	732.28M	-41.99M	-5.42%
Dec 31, 2021	774.27M	108.93M	16.37%
Dec 31, 2020	665.34M	274.50M	70.23%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	9.73B
Caliway Biopharmaceuticals	44.43M
Bora Pharmaceuticals Co., LTD.	19.25B
Lotus Pharmaceutical	18.58B
Polaris Group	107.00M
Oneness Biotech	117.93M
Pegavision	6.82B
Lumosa Therapeutics	39.15M

Revenue Rankings